These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6453633)

  • 1. Chemotherapy in non-seminomatous testicular tumours stage I.
    Ekman EP; Edsmyr F
    Br J Urol; 1981 Apr; 53(2):184-7. PubMed ID: 6453633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single drug therapy in non-seminomatous germinal cell tumours of the testicle.
    Ekman P
    Scand J Urol Nephrol; 1982; 16(1):37-43. PubMed ID: 6283625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy in stage II testicular tumours: preliminary communication.
    Höffken K; Schmidt CG
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 May; 86(1):103-8. PubMed ID: 132023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis for pathologic stage I non-seminomatous germ cell tumors of the testis managed by retroperitoneal lymphadenectomy.
    Johnson DE; Bracken RB; Blight EM
    J Urol; 1976 Jul; 116(1):63-5. PubMed ID: 933292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of retroperitoneal lymphadenectomy after chemotherapy for non-seminomatous testicular tumor with lymph node metastases.
    Le Guillou M; Ferriere JM; Brucher P; Mettetal PJ
    Prog Clin Biol Res; 1989; 303():813. PubMed ID: 2780677
    [No Abstract]   [Full Text] [Related]  

  • 7. Advances in the management of non-seminomatous germinal tumours of the testis.
    Skinner DG
    Br J Urol; 1977 Nov; 49(6):553-60. PubMed ID: 563269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mithramycin in advanced malignant testicular tumors].
    Klepp O; Hóst H; Klepp R; Lien HH; Tausjó J
    Tidsskr Nor Laegeforen; 1975 Jan; 95(1):23-8. PubMed ID: 163041
    [No Abstract]   [Full Text] [Related]  

  • 9. Para-aortic lymphadenectomy after chemotherapy for metastatic non-seminomatous germ cell tumours: prognostic value and therapeutic benefit.
    Hendry WF; A'Hern RP; Hetherington JW; Peckham MJ; Dearnaley DP; Horwich A
    Br J Urol; 1993 Feb; 71(2):208-13. PubMed ID: 8384914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer.
    Fosså SD; Aass N; Ous S; Høie J; Stenwig AE; Lien HH; Paus E; Kaalhus O
    J Urol; 1989 Nov; 142(5):1239-42. PubMed ID: 2478726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of treatment of non seminomatous germ cell tumours; 122 consecutive cases in the West of Scotland, 1981-1985.
    Graham J; Harding M; Mill L; Kerr DJ; Rankin E; Calman KC; Kaye SB
    Br J Cancer; 1988 Feb; 57(2):182-5. PubMed ID: 3358908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testicular tumors: 40 years' experience.
    Culp DA; Boatman DL; Wilson VB
    J Urol; 1973 Nov; 110(5):548-53. PubMed ID: 4796104
    [No Abstract]   [Full Text] [Related]  

  • 13. Retroperitoneal lymphadenectomy as adjunctive therapy in selected cases of advanced testicular carcinoma.
    Johnson DE; Bracken RB; Ayala AG; Samuels ML
    J Urol; 1976 Jul; 116(1):66-8. PubMed ID: 58998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mithramycin (NSC 24559) therapy of testicular tumors.
    Hill GJ; Sedransk N; Rochlin D; Bisel H; Andrews NC; Fletcher W; Schroeder JM; Wilson WL
    Cancer; 1972 Oct; 30(4):900-8. PubMed ID: 4342856
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mature teratoma following chemotherapy in bilateral testicular tumors--a critical contribution].
    Fichte A; von Paris V
    Z Urol Nephrol; 1985 Jun; 78(6):317-21. PubMed ID: 4036384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why retroperitoneal lymphadenectomy for testicular tumors?
    Caldwell WL
    J Urol; 1978 Jun; 119(6):754-8. PubMed ID: 660761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroperitoneal lymph node dissection (RPLND) post chemotherapy for non-seminomatous testicular neoplasms: what is the significance of residual masses at scanner control after chemotherapy and should they be removed?
    Solé-Balcells F; Villavicencio H; Germá R
    Prog Clin Biol Res; 1989; 303():759-62. PubMed ID: 2780671
    [No Abstract]   [Full Text] [Related]  

  • 18. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
    Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD
    Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of testicular germ cell tumors. Current status of the MAHO studies].
    Haas RJ; Schmidt P; Göbel U; Harms D
    Klin Padiatr; 1993; 205(4):225-30. PubMed ID: 8397320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The total number of retroperitoneal lymph nodes resected impacts clinical outcome after chemotherapy for metastatic testicular cancer.
    Carver BS; Cronin AM; Eggener S; Savage CJ; Motzer RJ; Bajorin D; Bosl GJ; Sheinfeld J
    Urology; 2010 Jun; 75(6):1431-5. PubMed ID: 20299079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.